Tuaminoheptane

Tuaminoheptane

Names
IUPAC name Heptan-2-amine
Identifiers
CAS Number	123-82-0 Y 6240-90-0 R Y 44745-29-1 S Y
3D model (Jmol)	Interactive image
Beilstein Reference	635676, 4652352 R, 1719086 S
ChemSpider	5401 Y 5360930 R Y 2016267 S Y
ECHA InfoCard	100.004.233
EC Number	204-655-522
KEGG	D07371 Y
MeSH	tuamine
PubChem CID	5603 6992808 R 2734517 S
RTECS number	MQ5425000 R01AB08 (WHO) (combinations)
UNII	Z0420GYD84 Y
UN number	1993
InChI InChI=1S/C7H17N/c1-3-4-5-6-7(2)8/h7H,3-6,8H2,1-2H3 Y Key: VSRBKQFNFZQRBM-UHFFFAOYSA-N Y
SMILES CCCCCC(C)N
Properties
Chemical formula	C7H17N
Molar mass	115.22 g·mol−1
Appearance	Colourless liquid
Density	0.766 g/mL
Boiling point	142.1 °C; 287.7 °F; 415.2 K
log P	2.429
Refractive index (nD)	1.418–1.419
Pharmacology
ATC code	R01AA11 (WHO)
Hazards
GHS pictograms
GHS signal word	WARNING
GHS hazard statements	H226, H315, H319, H335
GHS precautionary statements	P261, P305+351+338
EU classification (DSD)	Xi
R-phrases	R10, R36/37/38
S-phrases	S26, S36
Flash point	54 °C (129 °F; 327 K)
Lethal dose or concentration (LD, LC):
LD50 (median dose)	130 mg kg−1(subcutaneous, rat)
Related compounds
Related alkanamines	Methylhexanamine Hexamethylenediamine
Related compounds	Octamoxin
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Tuaminoheptane (or tuamine) is a nasal decongestant drug which is a sympathomimetic stimulant and vasoconstrictor. However, it can cause skin irritation, which limits its usefulness as a nasal decongestant. Oral preparations were once available, but are no longer produced. Side effects associated with the use of tuaminoheptane can include shortness of breath, tachycardia and hypertension.

Tuaminoheptane is on the 2011 list of prohibited substances published by the World Anti-Doping Agency.